Relationship between Early Menopause and Mental Health Problems

Choi, In Young; Choi, Young Eun; Nam, Hyun Ryung; Lee, Jae Woo; Park, Eun Chul; Jang, Sung In

doi:10.21215/kjfp.2018.8.1.87

Cited by 5 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Estrogen therapy showed neurology in animal and rat models; it helped neurological development. After looking at the neuroimages, it was confirmed that estrogen treatment would upgrade the brain actions of memory processing in human beings [52].…”

Section: Neurological Disordermentioning

confidence: 92%

Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review

Thasneem

Kalarani

Jayaprasad

et al. 2022

Middle East Fertil Soc J

View full text Add to dashboard Cite

Background Menopause is a biological process when a woman’s reproductive capability is no longer functional. A naturally or artificially caused premenopausal is known as early menopause occurs between the ages 40–45, which substantially impacts fertility and disease influenced by genetic plus environmental factors and their interactions. Women in early menopause are at greater risk of cardiovascular disease, general mortality, neurological disorders, osteoporosis, mental illness, and other problems. Main body A PubMed search of the electronic literature database yielded articles on early menopause and disease etiology. Several unique genes were identified, such as ESR1, ESR2, CYP1B1, BRSK1, HK3, andTMEM150B are associated with early menopause, and research focused on case-control, cohort, and cross-sectional studies are finding novel predisposition loci for early menopause. Conclusion The current study’s focus is to understand better the genetic aspects of early menopause. This knowledge will help researchers enhance EM etiology and identify biomarkers that may detect early development of the disease, allowing women at risk to begin family planning earlier.

show abstract

Section: Neurological Disordermentioning

confidence: 92%

Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review

Thasneem

Kalarani

Jayaprasad

et al. 2022

Middle East Fertil Soc J

View full text Add to dashboard Cite

show abstract

“…According to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, the lifetime prevalence of schizophrenia appears to be approximately 0.3-0.7%, although there is reported variation by race/ethnicity, across countries, and by geographic origin for immigrants and children of immigrants [ 3 ]. During their reproductive years, women have a higher prevalence of schizophrenia-spectrum disorders, and those with schizophrenia are more likely to experience early menopause than the general population [ 4 , 5 ]. Thus, a comprehensive review of the existing literature is necessary to provide insight into the effects of menopause on the course and outcome of schizophrenia-spectrum disorders in women.…”

Section: Introductionmentioning

confidence: 99%

Understanding the Impact of Menopause on Women With Schizophrenia-Spectrum Disorders: A Comprehensive Review

Tiwari¹,

Prasad²,

Wanjari³

et al. 2023

Cureus

View full text Add to dashboard Cite

Menopause is a physiological event in women's lives that typically transpires in midlife, denoting the cessation of ovarian function and ultimately leading to the end of reproductive capacity. However, women with schizophrenia-spectrum disorders may encounter unique challenges during this period because of the interaction between hormonal changes and their pre-existing mental health conditions. This literature review aims to investigate the consequences of menopause on women with schizophrenia-spectrum disorders, including modifications in symptomatology, cognitive function, and quality of life. Potential interventions will also be examined, including hormone replacement therapy and psychosocial support. The study findings suggest that menopause can worsen symptoms, such as hallucinations and delusions, and may also impair cognitive function, resulting in memory and executive function difficulties. Nevertheless, hormone replacement therapy and psychosocial support could offer potential avenues to manage symptoms and improve the quality of life for women with schizophrenia-spectrum disorders during menopause.

show abstract

“…42 These techniques increase the ability to cope with stress, adapt to different situations, and consequently reduce stress and anxiety. 43 Considering that psychological problems in POI are far more than normal menopause 44 and researches in this field are inadequate, the aim of this study was to determine the effect of CBT on stress and anxiety (primary outcomes) and self-esteem and depression (secondary outcomes) in women with premature ovarian insufficiency.…”

Section: Introductionmentioning

confidence: 99%

The effect of cognitive-behavioral therapy on stress and anxiety of women with premature ovarian insufficiency: A randomized controlled trial

et al. 2022

View full text Add to dashboard Cite

The aim of this study was to determine the effect of cognitive-behavioral therapy (CBT) on stress and anxiety (primary outcomes) and self-esteem and depression (secondary outcomes) in women with premature ovarian insufficiency (POI). This randomized controlled trial was performed on 50 women known with POI in Tabriz, Iran, in 2021. Participants were randomly assigned to CBT and control groups. CBT was provided in eight sessions of 45–60 min once a week with five to seven people. The Spielberger State-Trait Anxiety Inventory, Cohen Perceived Stress Scale, Beck Depression Inventory, and Rosenberg Self-Esteem Scale were used to collect data. After intervention, based on ANCOVA test by adjusting the baseline values, mean scores of stress (AMD: −10.97; 95% CI: −11.64 to −10.29), state anxiety (AMD: −14.76; 95% CI: −15.77 to −13.74), trait anxiety (AMD: −14.41; 95% CI: −15.47 to −13.74), and depression (AMD: −7.44; 95% CI: −8.41 to −6.46) were significantly lower in the CBT group compared to the control group. Also, mean score of self-esteem (AMD: 1.49; 95% CI: 1.06–1.92) was significantly higher in the CBT group compared to the control group. Regarding the effectiveness of CBT in promoting of mental health, it is suggested that healthcare providers use this method to improve mental health of women with POI. Trial registration Iranian Registry of Clinical Trials (IRCT): IRCT20120718010324N64. Date of registration: 14/02/2021. URL: https://en.irct.ir/user/trial/52024/view; date of first registration: 17/02/2021.

show abstract

Relationship between Early Menopause and Mental Health Problems

Cited by 5 publications

References 0 publications

Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review

Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review

Understanding the Impact of Menopause on Women With Schizophrenia-Spectrum Disorders: A Comprehensive Review

The effect of cognitive-behavioral therapy on stress and anxiety of women with premature ovarian insufficiency: A randomized controlled trial

Contact Info

Product

Resources

About